Mallick Dhiraj sold $6.1M of CBRS

Mallick Dhiraj (Chief Operating Officer) sold 36,131 shares of Cerebras Systems Inc. (CBRS) at an average of $169.28 ($162.24–$185.21, $6.12M total) across 29 trades on 2026-06-25.

Original reporting
SEC EDGAR · Mallick Dhiraj
Published Jun 29, 2026, 8:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 29, 2026, 8:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CBRS
Neutral
medium confidence
Mentioned
$CBRS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBRSNeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale by the COO on June 25, with a total value of ~$6.12M and holdings after the sale of 33,314 shares.

02

Market read

Traders may monitor for follow-on insider activity, but there is no new guidance, deal, or operational update in the filing.

03

What to watch

No 10b5-1 plan is stated, but the filing alone doesn’t reveal tax, diversification needs, or whether other insiders are buying/selling around the same period.

Relevance 6/10Novelty 5/10Timing: Form 4 filed June 29 for a June 25 insider sale

Background

The article is an SEC Form 4 insider transaction disclosure for Cerebras Systems Inc. (CBRS).

Company-level read

Ticker impact

$CBRSNeutralMedium confidence
Context

Cerebras COO Mallick Dhiraj sold 36,131 CBRS shares in an open-market transaction totaling about $6.12M, per Form 4 filed June 29.

Expected impact

Likely limited, short-lived impact unless follow-on selling or new company-specific news emerges.

Evidence & confidence

The filing discloses transaction size, price range, and that it was not under a pre-arranged 10b5-1 plan, which can increase interpretive sensitivity; however, it provides no new operational/financial information.

Market effects

Minimal; this is company-specific insider activity with no disclosed sector-wide signal.

None indicated.

None indicated.

Counterpoint

The sale could be routine liquidity/portfolio management; without additional context, it may not reflect negative fundamentals.

Key entities

  • Cerebras Systems Inc.

    CBRS, the company whose insider transaction is disclosed.

  • Mallick Dhiraj

    Chief Operating Officer who sold 36,131 shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CBRSMed

Why Cerebras Systems Stock Is Plummeting Today

Cerebras Systems (CBRS) shares fell 9.2% after UBS cut its price target by 24% to $250, citing tempered expectations. Despite the reduction, UBS maintains a buy rating, noting potential upside from OpenAI demand and AWS adoption. The stock has also faced criticism from Culper Research, which took a short position. Cerebras is set to report Q3 earnings on Nov. 12.

$CBRSMed

Why is Cerebras Systems stock sliding today?

Cerebras Systems (CBRS) stock fell 8.3% to a 52-week low of $98.50 after UBS cut its price target to $250 from $330, citing reduced near-term conviction. The decline follows a short-seller report alleging chip degradation and upcoming share unlocks. The stock is down 70% from its high, but analysts maintain Buy ratings.

$CBRSHigh

Cerebras Stock Falls as Short Seller Questions Chip Lifespan

Cerebras Systems (CBRS) fell 5.77% after short seller Culper Research alleged its AI chips have a lifespan of 1.5 to 2.5 years and questioned its technology claims. Cerebras has not responded. The drop follows a lockup expiration and reverses part of a previous rally. The stock is far below its 52-week high of $386.34.

$CBRSHigh

Cerebras Gains 10% on Oracle Cloud Deal as “AI Inference Demands Choice”

Cerebras Systems (CBRS) shares rose 10% and Oracle (ORCL) gained 4% on Oct. 27 after Oracle announced plans to offer Cerebras' AI inference on its cloud starting in 2027. The deal aims to provide customers with more AI chip options. Analysts estimate Cerebras' 2027 revenue at $2.95 billion, though no deal value was disclosed. Cerebras trades at roughly half its average forward price/sales multiple since its IPO.

$CBRSMed

Why Cerebras Systems Stock Jumped on Tuesday

Cerebras Systems (CBRS) stock rose 10.1% after announcing a partnership with Oracle (ORCL) to offer its AI chip technology to Oracle Cloud Infrastructure customers. The company's Wafer-Scale Engine (WSE) is promoted for its large size and reduced latency. Cerebras reported a 287% year-over-year increase in cloud revenue to $128 million in Q2, but continues to incur losses.